Galmed Pharmaceuticals (GLMD) Revenue (2016 - 2018)

Galmed Pharmaceuticals' Revenue history runs 3 years deep, the most recent figure standing at $1.5 million for Q3 2018.

• In Q3 2018, Revenue rose 449.45% year-over-year to $1.5 million; the TTM figure through Jun 2019 stood at $1.8 million (up 63.13% YoY), while the FY2018 annual figure was $2.0 million, up 87.83% from the prior year.
• Revenue was $1.5 million for Q3 2018 at Galmed Pharmaceuticals, up from $270000.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.5 million in Q3 2018 to a low of $193000.0 in Q3 2016.
• Historically, Revenue has averaged $398888.9 across 3 years, with a median of $270000.0 in 2017.
• The sharpest annual moves came in 2017 and 2018: Revenue changed 0.0% in 2017, then jumped 449.45% in 2018.
• A 3-year view of Revenue shows it stood at $274000.0 in 2016, then changed by 0.0% to $274000.0 in 2017, then jumped by 447.45% to $1.5 million in 2018.
• The last three Revenue figures came in at $1.5 million (Q3 2018), $270000.0 (Q2 2018), and $268000.0 (Q1 2018), per Business Quant data.